Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Hepatitis C Virus Seroprevalence in Mongolian Women Assessed by a Novel Multiplex Antibody Detection Assay.

Dondog B, Schnitzler P, Michael KM, Clifford G, Franceschi S, Pawlita M, Waterboer T.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1360-5. doi: 10.1158/1055-9965.EPI-15-0351. Epub 2015 Jul 13.

2.

Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study.

Farzan SF, Waterboer T, Gui J, Nelson HH, Li Z, Michael KM, Perry AE, Spencer SK, Demidenko E, Green AC, Pawlita M, Karagas MR.

Int J Cancer. 2013 Oct 1;133(7):1713-20. doi: 10.1002/ijc.28176. Epub 2013 Apr 22.

3.

Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin.

Iannacone MR, Gheit T, Waterboer T, Giuliano AR, Messina JL, Fenske NA, Cherpelis BS, Sondak VK, Roetzheim RG, Ferrer-Gil S, Michael KM, McKay-Chopin S, Pawlita M, Tommasino M, Rollison DE.

J Invest Dermatol. 2013 Jun;133(6):1512-20. doi: 10.1038/jid.2012.478. Epub 2013 Jan 10.

4.

Detection and typing of cutaneous human papillomavirus types--a comparison of three different methods.

Antonsson A, Michael KM, Pawlita M, Lehmann MD, Nindl I.

J Virol Methods. 2013 May;189(2):305-10. doi: 10.1016/j.jviromet.2012.10.010. Epub 2012 Nov 2.

PMID:
23124002
5.

Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin.

Iannacone MR, Gheit T, Waterboer T, Giuliano AR, Messina JL, Fenske NA, Cherpelis BS, Sondak VK, Roetzheim RG, Michael KM, Tommasino M, Pawlita M, Rollison DE.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1303-13. doi: 10.1158/1055-9965.EPI-12-0032. Epub 2012 Jun 15.

6.

Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin.

Iannacone MR, Wang W, Stockwell HG, O'Rourke K, Giuliano AR, Sondak VK, Messina JL, Roetzheim RG, Cherpelis BS, Fenske NA, Michael KM, Waterboer T, Pawlita M, Rollison DE.

J Infect Dis. 2012 Aug 1;206(3):399-406. doi: 10.1093/infdis/jis374. Epub 2012 Jun 1.

7.

People reducing risk and improving strength through exercise, diet, and drug adherence (PRAISEDD): a case report on long-term single site adoption.

Michael KM, Shaughnessy M, Resnick B.

Transl Behav Med. 2012 Jun;2(2):236-40. doi: 10.1007/s13142-012-0127-6.

8.

Study of squamous cell carcinoma associated with syringofibroadenoma for 105 types of human papillomavirus and for all currently known types of polyomaviruses.

Fernandez-Flores A, Suarez-Penaranda JM, Halec G, Michael KM, Schmitt M.

Appl Immunohistochem Mol Morphol. 2014 Oct;22(9):e41-4. doi: 10.1097/PAI.0b013e318244ff6a.

PMID:
22495378
9.

Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer.

Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J.

Am J Epidemiol. 2012 Apr 1;175(7):685-95. doi: 10.1093/aje/kwr373. Epub 2012 Mar 14.

PMID:
22419740
10.

Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus.

Waterboer T, Dondog B, Michael KM, Michel A, Schmitt M, Vaccarella S, Franceschi S, Clifford G, Pawlita M.

Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):287-93. doi: 10.1158/1055-9965.EPI-11-1001. Epub 2011 Dec 6.

11.

Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma.

Rollison DE, Giuliano AR, Messina JL, Fenske NA, Cherpelis BS, Sondak VK, Roetzheim RG, Iannacone MR, Michael KM, Gheit T, Waterboer T, Tommasino M, Pawlita M.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):74-81. doi: 10.1158/1055-9965.EPI-11-0764. Epub 2011 Oct 20.

12.

Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types.

Michael KM, Forslund O, Bacevskij O, Waterboer T, Bravo IG, Pawlita M, Schmitt M.

J Clin Microbiol. 2011 Oct;49(10):3560-7. doi: 10.1128/JCM.01173-11. Epub 2011 Aug 10.

13.

Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam.

Heiligenberg M, Michael KM, Kramer MA, Pawlita M, Prins M, Coutinho RA, Dukers-Muijrers NH, Waterboer T.

Sex Transm Dis. 2010 Nov;37(11):672-80. doi: 10.1097/OLQ.0b013e3181e71069.

PMID:
20729796
14.

Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study.

Karagas MR, Waterboer T, Li Z, Nelson HH, Michael KM, Bavinck JN, Perry AE, Spencer SK, Daling J, Green AC, Pawlita M; New Hampshire Skin Cancer Study Group.

BMJ. 2010 Jul 8;341:c2986. doi: 10.1136/bmj.c2986.

15.

An analysis of clustering of betapapillomavirus antibodies.

Mallitt KA, O'Rourke P, Bouwes Bavinck JN, Abeni D, de Koning MN, Feltkamp MC, Green AC, Quint WG, Michael KM, Pawlita M, Pfister H, Weissenborn S, Waterboer T, Neale RE; EPI-HPV-UV-CA Group.

J Gen Virol. 2010 Aug;91(Pt 8):2062-7. doi: 10.1099/vir.0.017970-0. Epub 2010 Apr 14.

PMID:
20392895
16.

Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.

Iannacone MR, Michael KM, Giuliano AR, Waterboer T, Pawlita M, Rollison DE.

J Infect Dis. 2010 Mar;201(5):760-9. doi: 10.1086/650466.

PMID:
20105078
17.

Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs.

Senger T, Schädlich L, Textor S, Klein C, Michael KM, Buck CB, Gissmann L.

Vaccine. 2010 Feb 10;28(6):1583-93. doi: 10.1016/j.vaccine.2009.11.048. Epub 2009 Dec 8.

PMID:
20003923
18.

Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls.

Michael KM, Waterboer T, Pfister H, Gariglio M, Majewski S, Favre M, Pawlita M.

J Invest Dermatol. 2010 Mar;130(3):841-8. doi: 10.1038/jid.2009.356. Epub 2009 Nov 19.

19.

The seroprevalence of human papillomavirus by immune status and by ethnicity in London.

Casabonne D, Waterboer T, Michael KM, Pawlita M, Mitchell L, Newton R, Harwood C, Proby C.

Infect Agent Cancer. 2009 Sep 14;4:14. doi: 10.1186/1750-9378-4-14.

20.

The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK.

Casabonne D, Waterboer T, Michael KM, Pawlita M, Lally A, Mitchell L, Imko-Walczuk B, Wojnarowska F, Newton R, Proby C, Harwood C.

Infect Agent Cancer. 2009 Sep 14;4:13. doi: 10.1186/1750-9378-4-13.

21.

Association of seborrhoeic warts with skin cancer in renal transplant recipients.

Lally A, Casabonne D, Waterboer T, Imko-Walczuk B, Michael KM, Pawlita M, Newton R, Wojnarowska F.

J Eur Acad Dermatol Venereol. 2010 Mar;24(3):302-7. doi: 10.1111/j.1468-3083.2009.03412.x. Epub 2009 Sep 1.

PMID:
19732252
22.

A case-control study of cutaneous squamous cell carcinoma among Caucasian organ transplant recipients: the role of antibodies against human papillomavirus and other risk factors.

Casabonne D, Lally A, Mitchell L, Michael KM, Waterboer T, Pawlita M, Imko-Walczuk B, Wojnarowska F, Proby C, Harwood C, Newton R.

Int J Cancer. 2009 Oct 15;125(8):1935-45. doi: 10.1002/ijc.24511. Erratum in: Int J Cancer. 2010 Mar 1;126(5):1282.

23.

Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia.

Waterboer T, Neale R, Michael KM, Sehr P, de Koning MN, Weissenborn SJ, Sampogna F, Abeni D, Green AC, Bouwes Bavinck JN, Pawlita M; EPI-HPV-UV-CA Group.

J Gen Virol. 2009 Aug;90(Pt 8):1986-98. doi: 10.1099/vir.0.010637-0. Epub 2009 Apr 22.

PMID:
19386782
24.
25.

High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis.

Dell'Oste V, Azzimonti B, De Andrea M, Mondini M, Zavattaro E, Leigheb G, Weissenborn SJ, Pfister H, Michael KM, Waterboer T, Pawlita M, Amantea A, Landolfo S, Gariglio M.

J Invest Dermatol. 2009 Apr;129(4):1026-34. doi: 10.1038/jid.2008.317. Epub 2008 Oct 16.

26.

Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers.

Rollison DE, Pawlita M, Giuliano AR, Iannacone MR, Sondak VK, Messina JL, Cruse CW, Fenske NA, Glass LF, Kienstra M, Michael KM, Waterboer T, Gheit T, Tommasino M.

Int J Cancer. 2008 Nov 15;123(10):2337-42. doi: 10.1002/ijc.23795.

27.

Surgical management of dural arteriovenous malformations of the cranium.

Michael KM, Drummond KJ, Sorby W, Grinnell V.

J Clin Neurosci. 1998 Jul;5(3):318-22.

PMID:
18639039
28.

Seroprevalence of 34 human papillomavirus types in the German general population.

Michael KM, Waterboer T, Sehr P, Rother A, Reidel U, Boeing H, Bravo IG, Schlehofer J, Gärtner BC, Pawlita M.

PLoS Pathog. 2008 Jun 20;4(6):e1000091. doi: 10.1371/journal.ppat.1000091.

29.

Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin.

Waterboer T, Abeni D, Sampogna F, Rother A, Masini C, Sehr P, Michael KM, Pawlita M.

Br J Dermatol. 2008 Aug;159(2):457-9. doi: 10.1111/j.1365-2133.2008.08621.x. Epub 2008 May 22.

PMID:
18503604
30.

Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types.

Rizk RZ, Christensen ND, Michael KM, Müller M, Sehr P, Waterboer T, Pawlita M.

J Gen Virol. 2008 Jan;89(Pt 1):117-29.

PMID:
18089735
31.
32.

Human papillomavirus infection among 100 oesophageal cancer cases in the People's Republic of China.

Dai M, Zhang WD, Clifford GM, Gheit T, He BC, Michael KM, Waterboer T, Hainaut P, Tommasino M, Franceschi S.

Int J Cancer. 2007 Sep 15;121(6):1396-8. No abstract available.

33.

Cardiovascular risk in survivors of stroke.

Kopunek SP, Michael KM, Shaughnessy M, Resnick B, Nahm ES, Whitall J, Goldberg A, Macko RF.

Am J Prev Med. 2007 May;32(5):408-12.

34.

When stroke strikes. Minimizing impact and maximizing recovery.

Shaughnessy M, Michael KM, Normandt P.

Adv Nurse Pract. 2006 Sep;14(9):26-33; quiz 34. Review. No abstract available.

PMID:
16972441
35.

Stroke prevention and management in older adults.

Michael KM, Shaughnessy M.

J Cardiovasc Nurs. 2006 Sep-Oct;21(5 Suppl 1):S21-6. Review.

PMID:
16966926
36.

Fatigue after stroke: relationship to mobility, fitness, ambulatory activity, social support, and falls efficacy.

Michael KM, Allen JK, Macko RF.

Rehabil Nurs. 2006 Sep-Oct;31(5):210-7.

PMID:
16948443
37.

Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins.

Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M.

Clin Chem. 2005 Oct;51(10):1845-53. Epub 2005 Aug 11.

38.

Reduced ambulatory activity after stroke: the role of balance, gait, and cardiovascular fitness.

Michael KM, Allen JK, Macko RF.

Arch Phys Med Rehabil. 2005 Aug;86(8):1552-6.

PMID:
16084807
39.

Steps after stroke: capturing ambulatory recovery.

Shaughnessy M, Michael KM, Sorkin JD, Macko RF.

Stroke. 2005 Jun;36(6):1305-7. Epub 2005 May 5.

PMID:
15879321
40.

A culture method as an aid for routine diagnosis of amebic infection in Ceylon.

MICHAEL KM, COORAY GH.

Am J Trop Med Hyg. 1952 Jul;1(4):543-7. No abstract available.

PMID:
14943900

Supplemental Content

Loading ...
Support Center